The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms, Trends in Immunology, vol.26, issue.9, pp.485-495, 2005. ,
DOI : 10.1016/j.it.2005.07.004
Review: Leucocyte-endothelial cell crosstalk at the blood-brain barrier: A prerequisite for successful immune cell entry to the brain, Neuropathology and Applied Neurobiology, vol.25, issue.1, pp.24-39, 2011. ,
DOI : 10.1111/j.1365-2990.2010.01140.x
Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis, Multiple Sclerosis, vol.13, issue.6, pp.701-707, 2007. ,
DOI : 10.1177/1352458506075378
Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species, Neurology, vol.45, issue.Issue 6, Supplement 6, pp.16-21, 1995. ,
DOI : 10.1212/WNL.45.6_Suppl_6.S16
Prevention of experimental autoimmune encephalomyelitis by antibodies against ??4??l integrin, Nature, vol.356, issue.6364, pp.63-66, 1992. ,
DOI : 10.1038/356063a0
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.354, issue.9, pp.899-910, 2006. ,
DOI : 10.1056/NEJMoa044397
Natalizumab treatment reduces endothelial activity in MS patients, Journal of Neuroimmunology, vol.227, issue.1-2, pp.190-194, 2010. ,
DOI : 10.1016/j.jneuroim.2010.07.012
Chronic neurologic disease in Theiler's virus infection of SJL/J mice, Journal of the Neurological Sciences, vol.30, issue.1, pp.201-207, 1976. ,
DOI : 10.1016/0022-510X(76)90267-7
Intracellular trafficking of anandamide: new concepts for signaling, Trends in Biochemical Sciences, vol.35, issue.11, pp.601-608, 2010. ,
DOI : 10.1016/j.tibs.2010.05.008
The endocannabinoid system as a target for the treatment of neurodegenerative disease, British Journal of Pharmacology, vol.400, issue.3, pp.480-498, 2010. ,
DOI : 10.1111/j.1476-5381.2010.00735.x
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis, Experimental Neurology, vol.224, issue.1, pp.92-102, 2010. ,
DOI : 10.1016/j.expneurol.2010.03.030
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity, Science, vol.302, issue.5642, pp.84-88, 2003. ,
DOI : 10.1126/science.1088208
URL : http://hdl.handle.net/11858/00-001M-0000-000E-9E00-4
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells, Neuron, vol.49, issue.1, pp.67-79, 2006. ,
DOI : 10.1016/j.neuron.2005.11.027
The endocannabinoid 2-AG protects the blood???brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines, Neurobiology of Disease, vol.22, issue.2, pp.257-264, 2006. ,
DOI : 10.1016/j.nbd.2005.11.004
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis, Brain, vol.130, issue.10, pp.2543-2553, 2007. ,
DOI : 10.1093/brain/awm160
Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?, Experimental Neurology, vol.224, issue.1, pp.37-47, 2010. ,
DOI : 10.1016/j.expneurol.2010.03.021
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis, Neurobiology of Disease, vol.20, issue.2, pp.207-217, 2005. ,
DOI : 10.1016/j.nbd.2005.03.002
Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis, The FASEB Journal, vol.19, pp.1338-1340, 2005. ,
DOI : 10.1096/fj.04-2464fje
The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases, Current Pharmaceutical Design, vol.14, issue.23, pp.2370-2342, 2008. ,
DOI : 10.2174/138161208785740018
Endocannabinoids control spasticity in a multiple sclerosis model, The FASEB Journal, vol.15, pp.300-302, 2001. ,
DOI : 10.1096/fj.00-0399fje
Therapeutic action of cannabinoids in a murine model of multiple sclerosis, J Neurosci, vol.23, pp.2511-2516, 2003. ,
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial, The Lancet, vol.362, issue.9395, pp.1517-1526, 2003. ,
DOI : 10.1016/S0140-6736(03)14738-1
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/ endothelial interactions in an experimental autoimmune encephalomyelitis model, Multiple Sclerosis, vol.10, issue.2, pp.158-164, 2004. ,
DOI : 10.1191/1352458504ms1009oa
A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules, Molecular and Cellular Neuroscience, vol.40, issue.2, pp.258-266, 2009. ,
DOI : 10.1016/j.mcn.2008.10.015
Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination, European Journal of Pharmacology, vol.372, issue.1, pp.75-83, 1999. ,
DOI : 10.1016/S0014-2999(99)00187-9
Interaction of ??4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro, Journal of Neuroimmunology, vol.102, issue.1, pp.32-43, 2000. ,
DOI : 10.1016/S0165-5728(99)00156-3
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood???brain barrier model for drug uptake and transport studies, Brain Research, vol.990, issue.1-2, pp.95-112, 2003. ,
DOI : 10.1016/S0006-8993(03)03443-7
Evaluation of bEnd5 cell line as an in vitro model for the blood???brain barrier under normal and hypoxic/aglycemic conditions, Journal of Pharmaceutical Sciences, vol.96, issue.12, pp.3196-3213, 2007. ,
DOI : 10.1002/jps.21002
Evidence for cyclooxygenase activation by nitric oxide in astrocytes, Glia, vol.247, issue.2, pp.167-172, 1995. ,
DOI : 10.1002/glia.440150209
Establishment and functional characterization of an in vitro model of the blood???brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes, European Journal of Pharmaceutical Sciences, vol.12, issue.3, pp.215-222, 2001. ,
DOI : 10.1016/S0928-0987(00)00123-8
Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood???brain barrier, Methods, vol.29, issue.4, pp.351-361, 2003. ,
DOI : 10.1016/S1046-2023(02)00359-6
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors, Molecular Brain Research, vol.132, issue.1, pp.87-92, 2004. ,
DOI : 10.1016/j.molbrainres.2004.08.025
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors, British Journal of Pharmacology, vol.100, issue.5, pp.576-582, 2007. ,
DOI : 10.1038/sj.bjp.0707423
CNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control, Current Pharmaceutical Design, vol.14, issue.23, pp.2266-2278, 2008. ,
DOI : 10.2174/138161208785740090
URL : http://doi.org/10.2174/138161208785740090
Mending the broken brain: neuroimmune interactions in neurogenesis, Journal of Neurochemistry, vol.9, issue.Suppl 1, pp.1277-1290, 2010. ,
DOI : 10.1111/j.1471-4159.2010.06849.x
Emerging strategies for exploiting cannabinoid receptor agonists as medicines, British Journal of Pharmacology, vol.152, issue.2, pp.397-411, 2009. ,
DOI : 10.1111/j.1476-5381.2008.00048.x
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis, Journal of Neuroimmunology, vol.193, issue.1-2, pp.120-129, 2008. ,
DOI : 10.1016/j.jneuroim.2007.10.024
Characteristics of cloned cerebrovascular endothelial cells following infection with Theiler's virus II. Persistent infection, Journal of Neuroimmunology, vol.62, issue.2, pp.127-135, 1995. ,
DOI : 10.1016/0165-5728(95)00094-4
Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease, International Immunology, vol.9, issue.12, pp.1837-1847, 1997. ,
DOI : 10.1093/intimm/9.12.1837
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection, Biochemical Pharmacology, vol.72, issue.7, pp.869-880, 2006. ,
DOI : 10.1016/j.bcp.2006.06.037
Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells, Thrombosis and Haemostasis, vol.95, pp.117-127, 2006. ,
DOI : 10.1160/TH05-06-0413
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells, The Journal of Immunology, vol.181, issue.9, pp.6406-6416, 2008. ,
DOI : 10.4049/jimmunol.181.9.6406
Cannabinoid Receptor and N-acyl Phosphatidylethanolamine Phospholipase D-Evidence for Altered Expression in Multiple Sclerosis, Brain Pathology, vol.4, 2011. ,
DOI : 10.1111/j.1750-3639.2011.00477.x
Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis, Journal of Neuroscience, vol.27, issue.9, pp.2396-402, 2007. ,
DOI : 10.1523/JNEUROSCI.4814-06.2007
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord, BMC Neurology, vol.3, issue.1, p.12, 2006. ,
DOI : 10.1016/S1471-4892(02)00004-8
Activation of Peroxisome Proliferator-Activated Receptor ?? (PPAR??) Suppresses Rho GTPases in Human Brain Microvascular Endothelial Cells and Inhibits Adhesion and Transendothelial Migration of HIV-1 Infected Monocytes, The Journal of Immunology, vol.180, issue.3, pp.1854-1865, 2008. ,
DOI : 10.4049/jimmunol.180.3.1854
Endothelial Cells from Diverse Tissues Exhibit Differences in Growth and Morphology, Microvascular Research, vol.55, issue.1, pp.65-76, 1998. ,
DOI : 10.1006/mvre.1997.2045
Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium, Microvascular Research, vol.69, issue.1-2, pp.28-35, 2005. ,
DOI : 10.1016/j.mvr.2005.02.001
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a ,
http://www.jneuroinflammation.com/content/8/1/102 therapeutic effect of palmitoylethanolamide, Journal of Neuroinflammation Eur J Neurosci, vol.8, issue.28, pp.102633-641, 2008. ,
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis, Journal of Neurochemistry, vol.118, issue.6 ,
DOI : 10.1111/j.1471-4159.2004.02979.x
cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction, British Journal of Pharmacology, vol.400, issue.7, pp.1251-1258, 2003. ,
DOI : 10.1038/sj.bjp.0705156
Endocannabinoids and their Involvement in the Neurovascular System, Current Neurovascular Research, vol.1, issue.2, pp.129-140, 2004. ,
DOI : 10.2174/1567202043480107
Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes, Glia, vol.23, issue.1, pp.85-90, 2003. ,
DOI : 10.1002/glia.10270
Endocannabinoid signaling in microglial cells, Neuropharmacology, vol.56, pp.244-253, 2009. ,
DOI : 10.1016/j.neuropharm.2008.07.037
Endocannabinoids and Traumatic Brain Injury, Molecular Neurobiology, vol.6, issue.suppl 11, pp.68-74, 2007. ,
DOI : 10.1007/s12035-007-8008-6
Immune control by endocannabinoids ??? New mechanisms of neuroprotection?, Journal of Neuroimmunology, vol.184, issue.1-2, pp.127-135, 2007. ,
DOI : 10.1016/j.jneuroim.2006.11.018
The Innate Immune Response Affects the Development of the Autoimmune Response in Theiler's Virus-Induced Demyelinating Disease, The Journal of Immunology, vol.182, issue.9, pp.5712-5722, 2009. ,
DOI : 10.4049/jimmunol.0801940
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway, FEBS Letters, vol.23, issue.1-2, pp.139-142, 1998. ,
DOI : 10.1016/S0014-5793(98)00851-5
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells, Brain, Behavior, and Immunity, vol.25, issue.4, pp.736-749, 2011. ,
DOI : 10.1016/j.bbi.2011.01.020
Differential Virus Replication, Cytokine Production, and Antigen-Presenting Function by Microglia from Susceptible and Resistant Mice Infected with Theiler's Virus, Journal of Virology, vol.81, issue.21, pp.11690-11702, 2007. ,
DOI : 10.1128/JVI.01034-07
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis, Brain, vol.126, issue.10, pp.2191-2202, 2003. ,
DOI : 10.1093/brain/awg224
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation, Neuroscience, vol.134, issue.1, pp.261-268, 2005. ,
DOI : 10.1016/j.neuroscience.2005.02.045
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain, Multiple Sclerosis Journal, vol.14, issue.1, pp.139-146, 2010. ,
DOI : 10.2307/2532296
receptor gene influences disease progression in relapsing multiple sclerosis, Multiple Sclerosis Journal, vol.95, issue.3, pp.281-288, 2011. ,
DOI : 10.1093/brain/awq076